Search

A drugmaker that's taking an unconventional approach to cancer drugs just got a $1.5 billion endorsement

A DRUGMAKER THAT'S TAKING AN UNCONVENTIONAL APPROACH TO CANCER DRUGS JUST GOT A $1.5 BILLION ENDORSEMENT

Bayer signed a partnership with cancer drugmaker Loxo Oncology in a deal that could be worth up to $1.5 billion. Loxo is developing...

In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs

IN A PRECISION STEP, BAYER WRITES LOXO $400M CHECK FOR TWO CANCER DRUGS

The latest evidence of the progress of targeted cancer drugs came this morning in the form of a $400 million check. That's what Bayer...

 
 
 
The nation's top cancer doctors are asking people to drink less in an unprecedented warning

THE NATION'S TOP CANCER DOCTORS ARE ASKING PEOPLE TO DRINK LESS IN AN UNPRECEDENTED WARNING

In a statement, the American Society of Clinical Oncology asked Americans to drink less alcohol. The group, which includes the nation's...

 
 
 
 
 
 

CLINICAL RESEARCH ASSOCIATE II - ONCOLOGY - HOME-BASED US - PREMIER RESEARCH - SAN DIEGO, CA

Monitoring data - remotely, on site, and via other approved modes - with a focus on data integrity and patient safety, in accordance...

 
 
 
Seattle Biotech Blaze Bioscience Adds $16M for Clinical Trial Work

SEATTLE BIOTECH BLAZE BIOSCIENCE ADDS $16M FOR CLINICAL TRIAL WORK

Blaze Bioscience, a Seattle-based biotech that's developing “tumor paint” to help surgeons differentiate healthy tissue from tumors...

ADMINISTRATIVE ASSISTANT - ONCOLOGY - CARLSBAD, CA

Requires the ability to quickly pick up on various IT systems to support data exports and various reporting tools...From Oncology -...

 
 
 
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More

BIO ROUNDUP: NOBEL PURSUIT, FUNDRAISING FRUIT, A RHYTHMIC IPO & MORE

The 2017 Nobel Prizes with a biomedical bent were announced this week. Three researchers shared the physiology and medicine prize for...

 
 
 
Pete's Bluebird Provides Ongoing and Heartfelt Support

PETE'S BLUEBIRD PROVIDES ONGOING AND HEARTFELT SUPPORT

In memory of their best friend Katie For siblings Bill Coniaris and Eleni “Stammy” Coniaris, Cummings School of Veterinary Medicine...

 
 
 

CULLINAN ONCOLOGY EMERGES WITH $150 MILLION AND A ROSTER OF ALL-STAR BIOTECH SCIENTISTS

Life Sciences Jobs ...

Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio

CULLINAN ONCOLOGY EMERGES WITH $150M TO BUILD CANCER DRUG PORTFOLIO

It's no secret that discovering and developing cancer drugs is an expensive and risky endeavor. But Cullinan Oncology is betting that...

 
 
 

CULLINAN BAGS $150M TO BUILD BROAD SLATE OF CANCER ASSETS

Cullinan Oncology has raised $150 million to build a portfolio of cancer R&D programs. The idea is to manage the risks inherent in...

Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

ENDOCYTE ADDS PHASE 3-READY PROSTATE CANCER DRUG WITH ABX DEAL

Four months after two Endocyte drug candidates stumbled in early-stage studies, sparking a corporate shakeup, the company has signed...

 
 
 
“Five Questions For. ” Austin Biotech Entrepreneur Paul Lammers

“FIVE QUESTIONS FOR. ” AUSTIN BIOTECH ENTREPRENEUR PAUL LAMMERS

Austin -Two years ago, Paul Lammers was riding the cancer immunotherapy wave in biotech. His firm, Mirna Therapeutics, hit the Nasdaq...